Search results
... Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American ...
Morningstar· 3 days agoThe survey found that 86 percent of... Mobi regardless of prior therapy and agreed that Tandem Mobi helps improve their quality of life.1 Tandem Mobi, the world’s smallest ...
Ozempic® (semaglutide) injection 1 mg demonstrated reduction in risk of kidney disease-related...
Benzinga· 22 hours agoSemaglutide 1 mg demonstrated a statistically significant and superior reduction of 24% in the risk of kidney disease-related events vs. placebo in adults with type ...
Vertex’s VX-880 shows promise in Phase I/II type 1 diabetes trial
Clinical Trials Arena via Yahoo Finance· 1 day ago"Vertex’s VX-880 shows promise in Phase I/II type 1 diabetes trial" was originally created and...
Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1
Morningstar· 3 hours agoDarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new studies presented this past weekend at the 84th Annual American ...
Can Metformin Cause Hair Loss?
MediaFeed via AOL· 1 day agoMetformin is a drug used to treat type 2 diabetes mellitus. While some may notice fallout or thinning when taking this medication, the connection might...
Postdoctoral position for EU project ARTiDe: A novel regulatory T celltherapy for type 1 diabetes -...
Nature· 5 days agoType 1 diabetes (T1D) is an incurable disease, often starting in childhood, caused by the autoimmune destruction of insulin-producing ...
Medtronic’s study shows reduced diabetes burden with MiniMed 780G system
Medical Device Network via Yahoo Finance· 1 day agoMedtronic has reported positive results from a study of its MiniMed 780G automated insulin delivery...
AstraZeneca makes another obesity play funnelling $80m into SixPeaks Bio
Clinical Trials Arena via Yahoo Finance· 11 minutes agoGlobalData estimates that GLP-1 receptor agonist sales for the type 2 diabetes (T2D) and obesity...
Pfizer's Working on the Next Wegovy, but Can It Beat Novo Nordisk?
Motley Fool via Yahoo Finance· 2 hours agoNordisk's (NYSE: NVO) smash-hit obesity therapy that's essentially a slightly different version of...
ADA Scientific Sessions 2024 Go Beyond Glucose and Obesity
Medscape· 6 days agoScientific Sessions committee chair Alice Cheng, MD, told Medscape Medical News, "What we're going...